Imrestor 15 mg solución inyectable para bovino

Страна: Испания

Язык: испанский

Источник: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

Купи это сейчас

Активный ингредиент:

PEGBOVIGRASTIM

Доступна с:

Eli Lilly And Company Ltd

код АТС:

QL03AA90

ИНН (Международная Имя):

PEGBOVIGRASTIM

Фармацевтическая форма:

SOLUCIÓN INYECTABLE

состав:

Excipientes: CITRICO ACIDO, MONOHIDRATO, L-ARGININA, AGUA PARA PREPARACIONES INYECTABLES, ARGININA, HIDROCLORURO DE

Администрация маршрут:

VÍA SUBCUTÁNEA

Тип рецепта:

Sujeto a prescripción veterinaria Sólo por el veterinario

Терапевтическая группа:

Novillas, Vacas

Терапевтические области:

Pegbovigrastim

Обзор продуктов:

Imrestor 15 mg solución inyectable para bovino Caja con 50 jeringas de 2,7 ml Autorizado Comercializado

Статус Авторизация:

Autorizado

Дата Авторизация:

2015-12-18

тонкая брошюра

                                [European Medicines Agency logo] European Medicines Agency - Science,
medicines, health [/]
    
Search for medicines ADVANCED DOCUMENT SEARCH
[/ema/index.jsp%3Fcurl=pages/document_library/landing/document_library_search.jsp]
MAIN NAVIGATION	*
Home [/ema/index.jsp%3Fcurl=pages/home/Home_Page.jsp&mid=]	*
Find medicine
[/ema/index.jsp%3Fcurl=pages/includes/medicines/medicines_landing_page.jsp&mid=]	*
Human regulatory
[/ema/index.jsp%3Fcurl=pages/regulation/landing/human_medicines_regulatory.jsp&mid=]	*
Veterinary regulatory
[/ema/index.jsp%3Fcurl=pages/regulation/landing/veterinary_medicines_regulatory.jsp&mid=]	*
Committees
[/ema/index.jsp%3Fcurl=pages/about_us/general/general_content_000217.jsp&mid=]	*
News & events
[/ema/index.jsp%3Fcurl=pages/news_and_events/landing/news_and_events.jsp&mid=]	*
Partners & networks
[/ema/index.jsp%3Fcurl=pages/partners_and_networks/general/general_content_000212.jsp&mid=]	*
About us
[/ema/index.jsp%3Fcurl=pages/about_us/document_listing/document_listing_000426.jsp&mid=]	*
HUMAN MEDICINES
[/../index.jsp%3Fcurl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124]	*
EUROPEAN PUBLIC ASSESSMENT REPORTS
[/../index.jsp%3Fcurl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d125]	*
EPARS: BACKGROUND AND CONTEXT
[/../index.jsp%3Fcurl=pages/medicines/general/general_content_000433.jsp&mid=WC0b01ac058067fa25]	*
PATIENT SAFETY
[/../index.jsp%3Fcurl=pages/medicines/landing/pha_listing.jsp&mid=WC0b01ac058001d126]	*
PENDING EC DECISIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/smop_search.jsp&mid=WC0b01ac058001d127]	*
WITHDRAWN APPLICATIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/wapp_search.jsp&mid=WC0b01ac058001d128]	*
PAEDIATRICS
[/../index.jsp%3Fcurl=pages/medicines/landing/pip_search.jsp&mid=WC0b01ac058001d129]	*
RARE DISEASE DESIGNATIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/orphan_search.jsp&mid=WC0b01ac058001d12b]	*
MEDICINES UNDER EVALUATION
[/../index.jsp%3Fcurl=pages/medicines/document_listing/document_listing_000349.jsp&mid=WC0b01ac0580508
                                
                                Прочитать полный документ
                                
                            

Характеристики продукта

                                [European Medicines Agency logo] European Medicines Agency - Science,
medicines, health [/]
    
Search for medicines ADVANCED DOCUMENT SEARCH
[/ema/index.jsp%3Fcurl=pages/document_library/landing/document_library_search.jsp]
MAIN NAVIGATION	*
Home [/ema/index.jsp%3Fcurl=pages/home/Home_Page.jsp&mid=]	*
Find medicine
[/ema/index.jsp%3Fcurl=pages/includes/medicines/medicines_landing_page.jsp&mid=]	*
Human regulatory
[/ema/index.jsp%3Fcurl=pages/regulation/landing/human_medicines_regulatory.jsp&mid=]	*
Veterinary regulatory
[/ema/index.jsp%3Fcurl=pages/regulation/landing/veterinary_medicines_regulatory.jsp&mid=]	*
Committees
[/ema/index.jsp%3Fcurl=pages/about_us/general/general_content_000217.jsp&mid=]	*
News & events
[/ema/index.jsp%3Fcurl=pages/news_and_events/landing/news_and_events.jsp&mid=]	*
Partners & networks
[/ema/index.jsp%3Fcurl=pages/partners_and_networks/general/general_content_000212.jsp&mid=]	*
About us
[/ema/index.jsp%3Fcurl=pages/about_us/document_listing/document_listing_000426.jsp&mid=]	*
HUMAN MEDICINES
[/../index.jsp%3Fcurl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124]	*
EUROPEAN PUBLIC ASSESSMENT REPORTS
[/../index.jsp%3Fcurl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d125]	*
EPARS: BACKGROUND AND CONTEXT
[/../index.jsp%3Fcurl=pages/medicines/general/general_content_000433.jsp&mid=WC0b01ac058067fa25]	*
PATIENT SAFETY
[/../index.jsp%3Fcurl=pages/medicines/landing/pha_listing.jsp&mid=WC0b01ac058001d126]	*
PENDING EC DECISIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/smop_search.jsp&mid=WC0b01ac058001d127]	*
WITHDRAWN APPLICATIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/wapp_search.jsp&mid=WC0b01ac058001d128]	*
PAEDIATRICS
[/../index.jsp%3Fcurl=pages/medicines/landing/pip_search.jsp&mid=WC0b01ac058001d129]	*
RARE DISEASE DESIGNATIONS
[/../index.jsp%3Fcurl=pages/medicines/landing/orphan_search.jsp&mid=WC0b01ac058001d12b]	*
MEDICINES UNDER EVALUATION
[/../index.jsp%3Fcurl=pages/medicines/document_listing/document_listing_000349.jsp&mid=WC0b01ac0580508
                                
                                Прочитать полный документ
                                
                            

Поиск оповещений, связанных с этим продуктом